Dr. Aseel Alsouqi from Ohio State University shared her perspective on the following fixed-duration CLL treatments. Watch her interviews to learn more! 

Venetoclax + obinutuzumab

Dr. Alsouqi explains the circumstances under which people with CLL may consider the fixed-duration combination of venetoclax and obinutuzumab. 

Venetoclax + rituximab 

Learn when venetoclax and rituximab may be appropriate as your CLL treatment. 

CAR T-cell therapy liso-cel

When should you consider receiving liso-cel? Learn from Dr. Alsouqi by watching her interview below.